Deerfield Management’s Sierra Oncology SRRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
– Sell
-44,122
Closed -$5.22M – 119
2018
Q2
$5.22M Hold
44,122
– – 0.18% 98
2018
Q1
$3.65M Buy
44,122
+95
+0.2% +$10.8K 0.13% 100
2017
Q4
$6.57M Sell
44,027
-25,973
-37% -$2.5M 0.26% 80
2017
Q3
$4.34M Sell
70,000
-17,393
-20% -$1.02M 0.2% 81
2017
Q2
$4.09M Sell
87,393
-36,915
-30% -$1.88M 0.22% 69
2017
Q1
$7.61M Buy
124,308
+95,143
+326% +$5.53M 0.29% 79
2016
Q4
$1.74M Sell
29,165
-5,513
-16% -$344K 0.07% 94
2016
Q3
$2.52M Sell
34,678
-5,540
-14% -$428K 0.12% 77
2016
Q2
$3.2M Sell
40,218
-34,815
-46% -$6.63M 0.13% 80
2016
Q1
$20.2M Buy
75,033
+30,252
+68% +$9.7M 0.86% 42
2015
Q4
$26.9M Buy
44,781
+11,071
+33% +$7.49M 1.09% 38
2015
Q3
$27.7M Buy
+33,710
New +$38M 1.07% 35

Other funds holding SRRA

Deerfield Management's SRRA Position: Q3 2018 in Review

Deerfield Management sold out of Sierra Oncology (SRRA) in Q3 2018, closing a stake of 44,122 shares — an estimated $5.22M sold.

Deerfield Management first reported a position in SRRA in Q3 2015 and held it in 12 quarters. The position peaked at $27.7M in Q3 2015. 60 funds tracked by Wall St. Rank hold SRRA as of Q3 2018.

  • Deerfield Management reported no remaining Sierra Oncology position as of Q3 2018 after selling out during the quarter.
  • Deerfield Management sold 44,122 Sierra Oncology shares in Q3 2018, an estimated $5.22M.
  • Deerfield Management first reported a position in Sierra Oncology in Q3 2015 and held it in 12 quarters.
  • Deerfield Management's Sierra Oncology position peaked at $27.7M in Q3 2015.
  • 60 funds tracked by Wall St. Rank held Sierra Oncology as of Q3 2018.

Based on Deerfield Management's 13F filing for Q3 2018, filed 14 Nov 2018.